Home > Boards > US Listed > Biotechs > Viking Therapeutics, Inc. (VKTX)

Thanks for clearing that up for me, so

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
greens12 Member Profile
 
Followed By 198
Posts 18,260
Boards Moderated 2
Alias Born 01/12/12
160x600 placeholder
Viking Therapeutics to Present at Biotech Showcase 2020 PR Newswire (US) - 1/6/2020 7:30:00 AM
Viking Therapeutics Announces Initiation of Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed Non-Alcoholic S... PR Newswire (US) - 11/19/2019 7:05:00 AM
Viking Therapeutics to Participate in Upcoming Investor Conferences PR Newswire (US) - 11/12/2019 7:30:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/5/2019 4:33:19 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/5/2019 7:16:14 AM
Viking Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update PR Newswire (US) - 11/5/2019 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/31/2019 6:28:06 PM
Viking Therapeutics to Report Financial Results for Third Quarter 2019 on November 5, 2019 PR Newswire (US) - 10/31/2019 7:30:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 10/10/2019 4:03:12 PM
Viking Therapeutics to Present at 2019 Cantor Global Healthcare Conference PR Newswire (US) - 9/25/2019 7:30:00 AM
Viking Therapeutics to Participate in Upcoming Investor Conferences PR Newswire (US) - 8/28/2019 7:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/2/2019 6:00:28 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 8/2/2019 6:08:04 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/2/2019 6:03:21 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/1/2019 5:17:57 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/1/2019 4:25:04 PM
Viking Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update PR Newswire (US) - 8/1/2019 4:05:00 PM
Viking Therapeutics to Report Financial Results for Second Quarter 2019 on August 1, 2019 PR Newswire (US) - 7/25/2019 4:05:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/2/2019 4:28:00 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 7/2/2019 4:24:53 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/2/2019 4:17:54 PM
Viking Therapeutics Appoints Kathy Rouan, Ph.D., to Board of Directors PR Newswire (US) - 7/2/2019 4:05:00 PM
Viking Therapeutics to Participate in Upcoming Investor Conferences PR Newswire (US) - 5/28/2019 7:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/23/2019 4:48:16 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/2/2019 5:12:42 PM
greens12   Sunday, 07/22/18 02:11:22 PM
Re: ZeWaffleBaron post# 1479
Post # of 1822 
Thanks for clearing that up for me, so Mid November is when the vk2809 news likely comes and with Conference call in August and full vk5211 data Sept 30 for vk5211 with a Partnership possible sometime in September or October the stock will be explosive from september thru November. With Partnership news possible the Nov $20 calls (and the $22.5 and the $25's might come well before November that way it wont be close to expiration deadline in November.
Hope you are enjoying the summer in CO. , stay well my friend. And GL to all on this board we have a Unicorn stock....keep holding long.



Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist